Egyptian International Pharmaceutical Industries Company reported consolidated and standalone earnings results for the first quarter ended March 31, 2019. For the quarter on consolidated basis, the company's net profit was EGP 218,314,348 against EGP 183,979,186. For the quarter on standalone basis, the company's net profit was EGP 203,315,743 against EGP 172,661,890.